Beshoy Armanios is a PhD candidate in Pharmacology and Toxicology in the department of Pharmaceutical Sciences at the University of Connecticut School of Pharmacy. He earned a B.S. in Biology from Providence College and an MPH in Epidemiology and Biostatistics from the University of Massachusetts Medical School. His doctoral research focuses on the regulatory role of long non-coding RNAs in liver health and metabolism using in vivo and multi-omic approaches. He brings diverse industry experience, including at Novo Nordisk, where he advanced nucleic acid delivery and characterization in macrophage models, and at Boehringer Ingelheim, where he supported preclinical drug development through drug-drug interaction analyses, in vitro–in vivo correlation studies, and co-authorship of a scientific manuscript. At Cyprotex, he contributed as an ADME/Tox scientist specializing in in vitro assay development, molecular biology techniques, bioinformatics, and LC-MS analysis. As a Clinical Research Coordinator at UMass, he supported neurocritical care projects and clinical study management. At UConn, Beshoy is actively involved in the Zhong Lab, co-authoring publications and book chapters on non-coding RNA regulation and drug interactions, while mentoring students in experimental design and data analysis. His research interests span therapeutic strategies for complex diseases, multi-omic integration, siRNA design, and innovative oligonucleotide delivery technologies.